Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy

Yi Wei Chung, Yao Hsu Yang, Cho Kai Wu, Chih Chieh Yu, Jyh Ming Jimmy Juang, Yi Chih Wang, Chia Ti Tsai, Lian Yu Lin, Ling Ping Lai, Juey Jen Hwang, Fu Tien Chiang, Pau Chung Chen, Jiunn Lee Lin*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science